VanEck Biotech ETF Newsroom

Cathie Wood's Ark Invest Loads Up On Intellia Therapeutics Which Laid Off Over A Quarter Of Its Workforce

Benzinga04:33 ET

Weekly Buzz: CES Came and Brought the Pain? That's Unexpected

Kevin Travers16:21 ET

Wall Street Today: Labor Gains Hurt a Hurting Market

Kevin Travers16:08 ET

The Analyst Verdict: Natera In The Eyes Of 14 Experts

Benzinga16:00 ET

Forecasting The Future: 22 Analyst Projections For Regeneron Pharmaceuticals

Benzinga15:00 ET

Gilead Upgraded by Morgan Stanley on Lenacapavir Potential

Seeking Alpha13:11 ET

Forecasting The Future: 23 Analyst Projections For Vertex Pharmaceuticals

Benzinga13:00 ET

This McDonald's Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday

Benzinga12:36 ET

4D Molecular, FDA Agree on Phase 3 Design for DME Candidate

Seeking Alpha11:18 ET

First Earnings Show Beats are Back, December Jobs Climbed but Market Falls Friday | Live Stock

Kevin Travers11:16 ET

Wells Fargo Maintains Overweight on Vertex Pharmaceuticals, Lowers Price Target to $460

BenzingaJan 10 09:12 ET · Ratings

Vertex Pharmaceuticals Analyst Ratings

BenzingaJan 10 09:12 ET · Ratings

Regeneron Pharmaceuticals Analyst Ratings

BenzingaJan 10 09:11 ET · Ratings

Pfizer Is 'Too Low To Sell,' Jim Cramer Says: Recommends Nvidia For Robotics Exposure

BenzingaJan 10 08:35 ET

Gilead Sciences Analyst Ratings

BenzingaJan 10 06:29 ET · Ratings

Pharma Companies Welcome New Year With 583 Drug Price Hikes so Far

Seeking AlphaJan 9 15:36 ET

Obesity Treatments, M&A Activity To Take Center Stage During Upcoming JPM Healthcare Conference

BenzingaJan 9 14:12 ET

Drugs Not Selected for Medicare Price Negotiation Nearly Doubled - Report

Seeking AlphaJan 9 11:35 ET

Novo, Eli Lilly to Dominate Global Pharma Sales in 2025: Report

Seeking AlphaJan 9 08:56 ET

S&P 500 Positive for 'First Five Days,' Huang Sees Decades till Quantum | Wall Street Today

Kevin TraversJan 8 16:12 ET